Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03029780
Brief Title: An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma (CheckMate 800)

First Submitted : January 20, 2017
First Submitted that Met QC Criteria : January 20, 2017
First Posted : January 24, 2017 (Estimate)

Results First Submitted : November 27, 2018
Results First Submitted that Met QC Criteria : November 27, 2018
Results First Posted : December 19, 2018

Last Update Submitted that Met QC Criteria : November 27, 2018
Last Update Posted : December 19, 2018